Ming-Sound Tsao

BSc Hons (BioChem),  1973


Dr.Ming-Sound Tsao is internationally recognized as one of the world’s leading Oncologic Pathologists and lung cancer researcher. He has published over 300 scientific papers in various highly ranked biomedical journals, including The New England Journal of Medicine, Nature and Journal of Clinical Oncology. His research has significantly advanced the understanding and use of molecular information to improve the treatment of lung cancer. His research team was among the first to define molecular markers that may be used in selection of patients for new targeted anti-cancer drugs. His team has also identified gene signatures that may predict outcome for patients with early stage non-small cell lung cancer, and may identify patients who may benefit from post-surgery chemotherapy. He has made significant contributions to international collaborative efforts in the molecular characterization of lung cancer.

Dr Tsao is a long-standing contributor to lung cancer clinical trials in Canada led by the NCIC Clinical Trials Group (CTG). His leadership in the molecular analyses of tumour samples from several seminal CTG trials has established Canada as a global leader in lung cancer research. He has also led several efforts to institute and standardize molecular testing in lung cancer across Canada. Dr Tsao was recently awarded the Canadian Cancer Society's O. Harold Warwick Prize. The prestigious honour, named after one of Canada's forefathers of cancer research, is given to a scientist whose research has had a major impact on controlling cancer in Canada.

Currently, Dr Tsao is a pathologist-scientist at the University Health Network (UHN) in Toronto where he holds the Qasim Choksi Chair in Lung Cancer Translational Research. He is a senior scientist at the Ontario Cancer Institute and professor of laboratory medicine and pathobiology at the University of Toronto. He co-chairs the NCIC CTG Correlative Science Tumour Biology Committee, associate editor of the Journal of Thoracic Oncology, editorial board member of the Journal of Clinical Oncology and member of the International Association for Study of Lung Cancer Committees in Pathology and in Staging. He is also the Chair of the Pathology Committee of the International Association for Study of Lung Cancer(IASLC).

To view a video interview with Dr. Tsao please visit:


Submitted by: Samuel  Tan


EducationHealth I Wellness Science I Technology


Biological Sciences


tribute thumbnail image tribute thumbnail image tribute thumbnail image tribute thumbnail image tribute thumbnail image tribute thumbnail image tribute thumbnail image tribute thumbnail image
tribute image